Results from the safety interim analysis of the adjuvant chemoradiotherapy in stomach tumors 2 trial: a multicenter, randomized phase III clinical trial
Se Hoon Park, Jeeyun Lee, Tae Sung Sohn, Do Hoon Lim, Kyoung-Mee Kim, Ji Yeong An, Min Gew Choi, Jun Ho Lee, Jae Moon Bae, Sung Kim, Su Jin Lee, Seung Tae Kim, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang
Precis Future Med. 2019;3(1):24-29.   Published online 2019 Mar 13     DOI: https://doi.org/10.23838/pfm.2018.00177
Citations to this article as recorded by Crossref logo
A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial
Se Hoon Park, Do Hoon Lim, Tae Sung Sohn, Jeeyun Lee, Dae Young Zang, Seung Tae Kim, Jung Hoon Kang, Sung Yong Oh, In Gyu Hwang, Jun Ho Ji, Dong Bok Shin, Jeong Il Yu, Kyoung-Mee Kim, Ji Yeong An, Min Gew Choi, Jun Ho Lee, Sung Kim, Jung Yong Hong, Joon O
Annals of Oncology.2020;[Epub]     CrossRef